Side effects in preventive maintenance therapy with neuroleptics with special emphasis on tardive dyskinesia.
Neuroleptics induce hypersensitivity reactions, and toxic, systemic and extrapyramidal manifestations. The latter mainly include acute dystonic reactions, other early dyskinesias, akathisia, parkinsonism and TD. These drugs have been implicated for DA antagonism exerted by an adenylate cyclase inhibition. Prolonged blockade of DA receptors is considered as the motivation for a counterbalancing mechanism inducing the DA supersensitivity from which TD results. Recent reports suggest cholinergic and GABA ergic insufficiency as secondary participants. The increasing frequency of TD calls for prevention by modifying treatment practices and searching for effective measures to combat the symptoms.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D002908:Chronic Disease; D004409:Dyskinesia, Drug-Induced / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D011618:Psychotic Disorders / Q000517:prevention & control*; D011954:Receptors, Dopamine / Q000187:drug effects; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D005680:gamma-Aminobutyric Acid